CancerWeb [ CancerWeb Home | Comments | Up One Level ]

Original Summaries of Selected CANCERLIT Records
Drug Delivery For Localized Uterine Cervical Disease

Last modified on: Tuesday, April 20, 1999 10:52:32
Copyright © 1994-2008, Information Ventures, Inc.

An interesting trial, carried out at the Queen's University of Belfast, Northern Ireland (McCarron; ICDB/95615334), used a cervical application analogous to a transdermal patch. Bioadhesion of available polymers displaying bioadhesive properties was achieved by designing and manufacturing a device that could quantitatively determine bioadhesive strength. Polymers such as sodium carboxymethylcellulose and Carbopol adhered strongly to the substrate material, excised cervical tissue. 5-Fluorouracil (5FU) was incorporated into films made from the bioadhesive polymers. A polyvinylchloride backing layer prevented back-diffusion and drug spill onto the vaginal epithelium. Release of 5FU from films and penetration into cervical tissue was rapid, reaching distribution equilibrium after approximately 4 hours. Increasing the patch dose increased the drug found in layers of tissue at specified depths from the tissue surface. Flux of 5FU through cervical tissue was almost two orders of magnitude greater than through untreated human skin. It was estimated that the patch was supplying 5FU at a level almost 2000 times that shown to cause cell death. The efficacy of the drug-loaded patch was studied in a double-blind clinical trial in patients with cervical intraepithelial neoplasia (CIN) I or II who received a 20 mg 5FU patch applied for 24 hours. Regression rates of CIN six months after application showed a remission rate of 80.4% for the drug-loaded patch, in comparison to a rate of 70.4% for the placebo. These initial findings are disappointing in that the remission rate in the control group was so high. Early- stage CIN frequently regresses spontaneously, so later stage disease might represent a better test system.

November, 1995


Copyright (c) 1994-2008, Information Ventures, Inc.
Mail us at: Customer-Service@infoventures.com
http://infoventures.com